A Zeng

ORCID: 0009-0006-4043-995X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Receptor Mechanisms and Signaling
  • Nanoplatforms for cancer theranostics
  • Nicotinic Acetylcholine Receptors Study
  • Cardiovascular Effects of Exercise
  • Prostate Cancer Treatment and Research
  • Neuropeptides and Animal Physiology
  • Cancer Immunotherapy and Biomarkers
  • Cytokine Signaling Pathways and Interactions
  • Estrogen and related hormone effects
  • Cardiac Arrest and Resuscitation
  • Photoreceptor and optogenetics research
  • Synthesis and biological activity
  • Sports injuries and prevention
  • Cancer, Stress, Anesthesia, and Immune Response
  • Laser Applications in Dentistry and Medicine

University of Washington
2024

State Key Laboratory of Biotherapy
2015

Sichuan University
2015

Abstract Breast carcinoma is the most common female cancer with considerable metastatic potential. Signal transducers and activators of transcription 3 (Stat3) signaling pathway constitutively activated in many cancers including breast has been validated as a novel potential anticancer target. Here, we reported our finding nifuroxazide, an antidiarrheal agent identified potent inhibitor Stat3. The potency nifuroxazide on was assessed vitro vivo . In this investigation, found that decreased...

10.1038/cddis.2015.63 article EN cc-by Cell Death and Disease 2015-03-26

Prostate cancer (PC) develops in a microenvironment where the stromal cells modulate adjacent tumor growth and progression. Here, we demonstrated elevated levels of monoamine oxidase B (MAOB), mitochondrial enzyme that degrades biogenic dietary monoamines, human PC stroma, which was associated with poor clinical outcomes patients. Knockdown or overexpression MAOB prostate fibroblasts indicated promotes cocultured cell proliferation, migration, invasion co-inoculated mice. Mechanistically,...

10.1126/sciadv.adi4935 article EN cc-by-nc Science Advances 2024-02-09

Abstract Introduction Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited associated with arrhythmias and increased risk of sudden cardiac death. Currently, there are no approved treatments that address the underlying genetic cause this disease, representing a significant unmet need. Purpose Mutations in desmosome gene Plakophilin-2 (PKP2) account for approximately 40% ARVC cases result reduced expression. Our goal to examine feasibility efficacy restoration PKP2...

10.1093/europace/euae102.606 article EN cc-by-nc EP Europace 2024-05-01
Coming Soon ...